Skip to content
10-Q

Quarterly Report

BIOSYNERGY INC

0001344676-20-000165

← back to feed
Filed
Dec 15, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Oct 31, 2020 14.94M sh
Cash And Equivalents Q2 2020 · Oct 31, 2020 $1.26M
Cash And Equivalents Q2 2020 · Apr 30, 2020 $1.25M
Cash And Equivalents Q2 2020 · Oct 31, 2019 $1.22M
Cash And Equivalents Q2 2020 · Apr 30, 2019 $1.18M
Stockholders Equity Q2 2020 · Oct 31, 2020 $1.74M
Stockholders Equity Q2 2020 · Apr 30, 2020 $1.72M
Current Liabilities Q2 2020 · Oct 31, 2020 $132.53K
Current Liabilities Q2 2020 · Apr 30, 2020 $166.79K
Current Assets Q2 2020 · Oct 31, 2020 $1.69M
Current Assets Q2 2020 · Apr 30, 2020 $1.7M
Total Assets Q2 2020 · Oct 31, 2020 $1.94M
Total Assets Q2 2020 · Apr 30, 2020 $2.01M
Operating Cash Flow Q2 2020 · Oct 31, 2019 $44.05K
Sga Expense Q2 2020 · Oct 31, 2019 $97.68K
Sga Expense Q2 2020 · Oct 31, 2019 $208.19K
Rd Expense Q2 2020 · Oct 31, 2019 $39.18K
Rd Expense Q2 2020 · Oct 31, 2019 $79.1K
Net Income Q2 2020 · Oct 31, 2019 $16.99K
Net Income Q2 2020 · Oct 31, 2019 $25.57K
Operating Income Q2 2020 · Oct 31, 2019 $23.13K
Operating Income Q2 2020 · Oct 31, 2019 $34.5K
Gross Profit Q2 2020 · Oct 31, 2019 $203.75K
Gross Profit Q2 2020 · Oct 31, 2019 $413.36K